Biocept Launches PD-L1 Liquid Biopsy Test

Biocept has introduced its PD-L1 protein expression test, the company announced Tuesday, broadening the company’s menu of liquid biopsy options.

The test, which is designed for use on the company’s Target Selector platform, pulls circulating tumor cells from a blood sample to profile and monitor PD-L1 protein expression. — Anisa Jibrell